RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazil's Anvisa to Open Consultation on Single-Facility Multiple-Product Production

Brazil's Anvisa to Open Consultation on Single-Facility Multiple-Product Production

Posted 19 July 2013 | By Louise Zornoza

Brazil's National Agency for Sanitary Surveillance (Anvisa) will soon open a Public Consultation (No. 26/2013) on a proposal to permit the production of veterinary pharmaceuticals, medical devices, cosmetics and toiletries in the same manufacturing site where human medicines are produced, it has announced.

Anvisa's said the proposal would, in its opinion, bring Brazil into alignment with regulatory policies in most other countries surveyed by the agency. Anvisa noted the need for public feedback on the proposal, given the complexity of the issue with the involvement of multiple regulated product sectors. 

The proposal will be open to public consultation starting 22 July 2013.

ANVISA Proposal

Read all Breaking News from RegLink

 

© 2022 Regulatory Affairs Professionals Society.

Tags: brazil

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe